ACVR2B antibody (Middle Region)
Quick Overview for ACVR2B antibody (Middle Region) (ABIN2782111)
Target
See all ACVR2B AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- Middle Region
- 
                                            Sequence
- KSKNVLLKSD LTAVLADFGL AVRFEPGKPP GDTHGQVGTR RYMAPEVLEG
- 
                                            Predicted Reactivity
- Cow: 100%, Dog: 100%, Goat: 85%, Guinea Pig: 100%, Horse: 100%, Human: 100%, Mouse: 100%, Rabbit: 77%, Rat: 100%, Sheep: 100%, Zebrafish: 100%
- 
                                            Characteristics
- This is a rabbit polyclonal antibody against ACVR2B. It was validated on Western Blot.
- 
                                            Purification
- Affinity Purified
- 
                                            Immunogen
- The immunogen is a synthetic peptide directed towards the middle region of human ACVR2B
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- Optimal working dilutions should be determined experimentally by the investigator.
- 
                                            Comment
- 
                        Antigen size: 512 AA 
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- Lot specific
- 
                                            Buffer
- Liquid. Purified antibody supplied in 1x PBS buffer with 0.09 % (w/v) sodium azide and 2 % sucrose.
- 
                                            Preservative
- Sodium azide
- 
                                            Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            Handling Advice
- Avoid repeated freeze-thaw cycles.
- 
                                            Storage
- -20 °C
- 
                                            Storage Comment
- For short term use, store at 2-8°C up to 1 week. For long term storage, store at -20°C in small aliquots to prevent freeze-thaw cycles.
 
- 
                                            
- 
    - ACVR2B (Activin A Receptor, Type IIB (ACVR2B))
- 
                                            Alternative Name
- ACVR2B
- 
                                            Background
- 
                        Activin receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling, and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Type II receptors are considered to be constitutively active kinases. ACVR2B is activin A type IIB receptor, which displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor.
 Alias Symbols: ACTRIIB, ActR-IIB, MGC116908, HTX4
 Protein Interaction Partner: GDF2, BMP10, INHBA, PEG10, ERBB2IP, HSP90AA1, SMAD7, SMAD6, SMAD2, IGSF1, SYNJ2BP, SNX6, SNX2, TGFBRAP1, GDF11, MSTN, ACVR1B, SNX1, INHBC, GDF5, INHBB, BMP7, BMP2, ENG, BMP6,
 Protein Size: 512
- 
                                            Molecular Weight
- 58 kDa
- 
                                            Gene ID
- 93
- 
                                            NCBI Accession
- NM_001106, NP_001097
- 
                                            UniProt
- Q13705
- 
                                            Pathways
- Hormone Transport, Cancer Immune Checkpoints
 Target
- 
                    
 
                                     
                                     
                                    